Brief: Addex Reports Q3 Loss Per Share CHF 0.09
Nov 11 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX REPORTS Q3 2022 FINANCIAL RESULTS AND PROVIDES
CORPORATE
UPDATE
* FOR THE THIRD QUARTER OF 2022, THE BASIC AND DILUTED LOSS
PER
SHARE DECREASED TO CHF 0.09
Source text for Eikon: ID:nGNX8WYrBB
Further company coverage: ADXN.S
((Reuters.briefs@thomsonreuters.com;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand